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Background: The aims of this study were: 1) to assess the frequency of insomnia among patients during admission
in a Palliative Care Unit (PCU); 2) to study the association between emotional distress and insomnia, taking physical,
environmental and other psychological factors into account.
Methods: Prospective observational study including patients consecutively admitted to a PCU during eight months,
excluding those with severe cognitive problems or too low performance status. Insomnia was assessed by asking a
single question and by using the Sleep Disturbance Scale (SDS), and emotional distress using the Hospital Anxiety
and Depression Scale (HADS). Physical, environmental and other psychological factors potentially interfering with
sleep quality were evaluated. Association between insomnia and the factors evaluated was studied using univariate
and multivariate regression analyses.
Results: 61 patients were included (mean age 71.5 years; 95% with oncological disease); 38 (62%) answered “yes”
to the insomnia single question and 29 (47%) showed moderate to severe insomnia according to the SDS. 65%
showed clinically significant emotional distress and 79% had nocturnal rumination. The physical symptoms most
often mentioned as interfering with sleep quality were pain (69%) and dyspnoea (36%). 77% reported at least one
environmental disturbance. In the univariate analysis, answering “yes” to the insomnia single question was
significantly associated with higher HADS score, anxiety, nocturnal rumination, clear knowledge of the diagnosis,
higher performance status and dyspnoea; moderate to severe insomnia was significantly associated with
nocturnal rumination, higher performance status, environmental disturbances and daytime sleepiness. In the
multivariate regression analysis, answering “yes” to the single question was associated with dyspnoea (OR 7.2
[1.65-31.27]; p = 0.009), nocturnal rumination (OR 5.5 [1.05-28.49]; p = 0.04) and higher performance status
(OR 14.3 [1.62-125.43]; p = 0.017), and moderate to severe insomnia with nocturnal rumination (OR 5.6 [1.1-29.1];
p = 0.041), and inversely associated with daytime sleepiness (OR 0.25 [0.07-0.9]; p = 0.043).
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Conclusions: Insomnia was highly frequent. Several physical, psychological and environmental factors seemed to
influence insomnia. Within the multimodal management of insomnia, the assessment of nocturnal rumination may be
of particular interest, irrespective of emotional distress. Further studies with larger sample sizes could confirm this result.
Keywords: Palliative care [MeSH], Sleep disorders [MeSH], Insomnia, Rumination, Oncology, Symptom assessment
[MeSH], Sleep Disturbance ScaleBackground
The prevalence of insomnia among persons with cancer
is higher than in the general population (up to 50%
versus 4-22%) [1-3]; its prevalence among patients with
advanced cancer admitted to Palliative Care Units
(PCUs) has been estimated as being between 45% and
95% [4,5]. Nevertheless, insomnia has received little
attention from the oncology community compared with
other symptoms such as pain and fatigue [6].
Insomnia is defined as the subjective perception of
difficulty with sleep initiation, duration, consolidation,
or quality that occurs despite adequate opportunity for
sleep and results in some form of daytime impairment
[7]. Insomnia is strongly correlated with patient satisfac-
tion and with quality of life in cancer [6,8]. It brings pa-
tients discomfort and suffering, and has physical and
psychological consequences such as increase of fatigue,
pain intolerance, irritability and depressive mood [6,9].
However, patients tend to underreport insomnia [10],
and the routine clinical assessment of insomnia is often
suboptimal.
The primary goal of the treatment of insomnia should
be first to relieve any underlying disorder that may be
causing the sleep disturbance. As a variety of factors
may influence insomnia in hospitalised patients suffering
from advanced cancer, a multimodal treatment, including
both pharmacologic and non-pharmacologic therapies,
should be considered. A plan combining attention to sleep
hygiene and cognitive-behavioral therapy with prescrip-
tion of hypnotic medications may help to relieve insomnia
in cancer patients and improve their quality of life [6].
In the literature, a variety of factors that may influence
sleep quality among palliative care patients have been
mentioned. The factors associated with insomnia most
commonly cited are pain and psychological symptoms.
Uncontrolled pain, pain treatment and “interference of
pain with mood” have been suggested as being associated
with insomnia [11-13], as well as low or variable moods,
dreams, concerns, hopelessness, post-traumatic experience,
anxiety and depression [4,11,13-16]. Anxiety has been
associated with difficulties in falling asleep, with less
restoring sleep and with nightmares, while depression
has been associated with early awaking, non-restorative
sleep, fatigue, nightmares and insomnia according to the
Pittsburgh Sleep Quality Index [5,15]. However, only afew studies have used specific and validated tools for the
assessment of psychological symptoms in relation to
insomnia [5,11].
Other factors which could influence insomnia in can-
cer population are age, performance status and certain
pharmacological treatments [11,14]. Female gender and
non-white race, as well as excessive consumption of
coffee and/or alcohol, or certain physical problems like
chronic kidney disease may also increase the risk of
incident insomnia in the general population [17]. Em-
pirical evidence suggests that biological factors such as
cytokines [18,19], genetic and metabolic disorders [20]
and cortisol awaking response [19,21] can contribute to
the disruption of the sleep cycle.
Environmental factors, and especially those in PCUs as
for example interruptions during the night by the nursing
staff, noise coming from the ward or from another patient
in the same room, or even having a room for individual
use, could influence the sleep quality of the patients
during admission. However, most studies evaluating
the factors associated with insomnia have not taken
environmental factors into account.
Patients are admitted to PCUs for rapid symptom con-
trol and intensive psychosocial care, normally for relatively
short periods. The length of stay may vary from two days
to more than two weeks [22,23]. Disturbing symptoms are
evaluated daily by professionals in PCUs, as their intensity
and characteristics can change from one day to the next.
Evaluating the presence of insomnia specifically during
admission to PCU, instead of evaluating persistent or
chronic insomnia, may help professionals to adapt the
management of insomnia, taking the changing situation
of symptoms, possible acute disease and type of unit
into account. Studies evaluating the prevalence of in-
somnia in this population have often used instruments
which refer to the preceding 15 days or four weeks or
which take relatively long to respond to, making their
use more difficult and less specific for the evaluation of
insomnia during admission in PCUs [24]. Other studies
have used a single question [12,25].
The aims of the present study were: 1) to evaluate the
frequency of insomnia during hospitalisation among the
patients admitted to a PCU by asking a single question
and by using an assessment tool that fits the character-
istics of this population (the 3-item questionnaire Sleep
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tween insomnia and emotional distress, considering both
anxiety and depression and using a validated tool, and tak-
ing also physical, environmental and other psychological
factors into account.
Methods
Study design
A prospective observational study design was used.
Participants and setting
Participants were patients admitted consecutively to the
PCU in a university hospital in Barcelona, Spain. This
PCU receives patients referred from both acute care hos-
pitalisation units and home care and has a mean length of
stay of 15 days. A sample size of 60 patients was calculated
to detect a difference of 35% in the presence of clinically
significant emotional distress between patients with and
without insomnia, considering that 50% of the patients
would suffer from insomnia and assuming an alpha error
of 5% and statistical power of 80%. Data inclusion went on
over an eight-month period and finished in October 2009.
The inclusion criteria were: 1) being admitted to PCU
during this period; 2) acceptable performance status
(defined as Karnofsky Index ≥ 30); 3) acceptable cognitive
status (defined as Pfeiffer Index ≤ 4 errors); and hospital
stay for > 2 nights.
Procedure
A Case Report Form (CRF) was developed after a literature
review. Approval of the study protocol and the CRF was
obtained by the hospital’s Ethical Committee for Clinical
Research (Comitè Ètic d’Investigació Clínica del Parc de
Salut Mar). The study was conducted in accordance with
the Declaration of Helsinki. The interviewers assessed the
newly admitted patients for eligibility and obtained their
oral informed consent for participation. Then the face-
to-face interview took place. Finally, a researcher (ARG)
extracted demographic data from the computerized
database of the hospital.
Interviewers were nursing staff employed at the PCU,
and had been trained by a researcher (ARG) or one expe-
rienced nurse (MS) to administer the survey in a stan-
dardized way.
Interviews were intended to take place between days
3 and 7 of admission. This was achieved for 41 of the
participants (67.2%). The interview with 3 participants
(4.9%) took place before day 3 and after day 7 with 17
participants (27.9%).
Measures
Assessment of insomnia
Two instruments were considered of interest and applied
to all included patients for the assessment of insomnia:1. Insomnia single question. Patients were asked “Have
you been suffering from insomnia since you have
been admitted?” Possible answers were “yes”, “no” or
“occasionally”. Although this is a non-validated
question, we considered that it could be of clinical
interest. A similar question was used in a previous
study, in which patients were asked “Do you have
trouble sleeping at night?” and given three possible
answers (“yes”, “no”, “occasionally”) [12]; while
none of the participants answered “no”, the answer
“occasionally” may have identified those patients
with less insomnia. Therefore, for the deductive
analyses of the present study, researchers compared
those participants answering “yes” with those
answering “no” or “occasionally”.
2. Sleep questionnaire. The Sleep Disturbance Scale
(SDS), developed in the context of the study by
Anderson et al. [26], was chosen because it is short
and refers to the previous 24 hours. The SDS
assesses three main sleep items: difficulty in falling
asleep, waking up during the night and waking up
too early in the morning. Patients are asked to score
each item on a Likert scale from 0 to 10. An overall
sleep disturbance score is calculated as the average
of the rated scores of the three sleep items. Patients
are classified in those with moderate to severe
insomnia (overall sleep disturbance score ≥ 5) and
those without moderate to severe insomnia (overall
sleep disturbance score < 5). In the original study
[26], the SDS demonstrated adequate internal
reliability with a coefficient alpha of 0.71. Construct
validity was supported by factor analysis and a single
underlying construct was identified. The scale
includes a final independent item asking patients to
judge the total number of hours they sleep per
night. Patients are classified in those who report
sleeping < 5 hours and those who report sleeping ≥ 5
hours per night. The scale was translated into
Catalan by one of the researchers (ARG) and the
time reference was widened to “since you have been
admitted”.
Additionally, patients were asked to rate how worried
about insomnia they were, using a Likert scale from 0
to 5. A score of ≥ 3 was considered as moderate worry.
Patients were asked if they suffered from daytime
sleepiness, feeling of non-restorative sleep, and when
insomnia had started (before diagnosis of the current
disease, after diagnosis or after admission to the PCU).
Assessment of emotional distress and other factors
potentially associated with insomnia
The main outcome variable was emotional distress, which
was measured using the Hospital Anxiety and Depression
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used with patients with advanced oncological disease
and validated in a Spanish population [27,28]. Clinically
significant emotional distress was considered if the
HADS score was ≥ 19. HADS includes two subscales,
separately evaluating clinical anxiety and depression. A
score of ≥ 11 for each subscale indicates anxiety or
depressed mood, respectively [29].
Other psychological factors as well as physical and en-
vironmental factors potentially associated with insomnia
were assessed.
Other psychological aspects evaluated were presence
of nightmares, feeling of fear or loneliness and presence
of nocturnal rumination, the latter being defined as
repetitively thinking about personal difficulties and
feelings, their causes, meanings, and consequences
[30,31]. The degree of information about the diagno-
sis and prognosis of the present disease was rated by the
interviewer according to his/her impression after the
interview.
Physical symptoms were assessed by asking patients
whether the following symptoms interfered with their
sleep quality: dyspnoea, functional incontinence, fever,
sweating, nausea or vomiting, itch, pain, drug or tobacco
abstinence, nycturia, cough and restless-legs.
The assessment of environmental factors consisted of
asking the patients if light or noise in their shared room
or coming from the ward, or interruptions by nurses
were interfering with the quality of their sleep. Patients
giving a positive answer to any of these questions were
considered to have “environmental disturbances”. Fur-
thermore, information was collected as to whether the
patient slept in an individual room and whether the family
stayed with him/her during the night. Patients were asked
if they had sleep habits at home that could not be accom-
plished at the PCU.
Patients’ perspective on the group of factors that interfered
most
Finally, patients were asked which of the three mentioned
groups of factors interfered most with the quality of their
sleep.
Other variables
Sociodemographic data, location before admission (home
or acute care), death during PCU stay, information on the
diagnosis and stage of the disease, comorbidity and medi-
cation were collected from the patients’ records in the
computerized database of the hospital.
Data analysis
All statistical analyses were performed using SPSS 15.0
package (SPSS Inc., Chicago, IL). Means, standard de-
viations and ranges were calculated for the scalevariables. Basic descriptive statistics were computed
for the sociodemographic variables, other aspects in
relation with insomnia and factors potentially associ-
ated with insomnia.
Univariate analyses were performed in order to inves-
tigate associations between insomnia and the factors
evaluated. Student’s T test, Chi-square and Fisher’s Exact
Test were used, depending on the type of the scale and
the distribution of the categories. Multivariate logistic
regression analyses were performed, including those
variables significantly associated with insomnia in the
univariate analyses which the researchers judged as
clinically meaningful, in order to investigate associations
between the factors and presence of insomnia using the
two instruments. Manual backward stepwise strategy was
used to remove non-significant variables of the model,
taking possible confounding factors into account, until a
final model was obtained. P values less than 0.05 were
considered statistically significant.
Results
One hundred and seventy-six patients were consecutively
admitted to the PCU during the eight-month period.
Sixty-one patients (34.7%) fulfilled the inclusion criteria.
Thirty-four of them were men and 27 women, and their
mean age was 71.5 ± 11 years. The majority of included
patients suffered from cancer (95.1%), with a high preva-
lence of metastatic cancer.
Ninety-five patients (54.0%) could not be included
because either they did not give informed consent (n = 2)
or they did not fulfil the inclusion criteria because they
were too cognitively impaired (n = 34), had a Karnofsky
Index < 30 (n = 44), spent less than two nights at the PCU
(n = 8), or had a Karnofsky Index < 30 and spent less than
two nights at the PCU (n = 7).
Twenty admitted patients (11.4%) were not assessed
for inclusion either because they died (n = 5), or were
discharged (n = 15) before assessment.
Table 1 shows the characteristics of the patients who
were included, those who were excluded and those who
were not assessed. Excluded and not assessed patients
did not differ significantly from included patients in terms
of age, gender, main diagnosis and stage of the disease.
However, significantly more patients in the groups of ex-
cluded (p < 0.001) and not assessed (p = 0.024) patients
died during admission in the PCU than in the group of in-
cluded patients.
Frequency of insomnia and other aspects in relation with
insomnia
Results on the frequency of insomnia and other aspects
in relation with insomnia are displayed in Table 2.
Thirty-eight of the included patients (62.3%) answered
“yes” to the insomnia single question, 13 patients (21.3%)
Table 1 Sociodemographic and clinical characteristics of the patients
Variable Included (n = 61) Not included (n = 95) Not assessed (n = 20)
n (%) n (%) n (%)
Sex (man) 34 (55.7) 54 (56.8) 12 (60.0)
Mean age ± SD, years 71.5 ± 11 73.3 ± 13.23 72.4 ± 10.90
Mean Pfeiffer Index ± SD (range 0-10)a 1.3 ± 1.08 not available not available
Karnofsky Index (range 0-100)b
≤ 50 45 (73.8) not available not available
> 50 16 (26.2) not available not available
Main diagnosis
Oncological 58 (95.1) 84 (88.4) 18 (90.0)
Non-oncological 3 (4.9) 11 (11.6) 2 (10.0)
Cancer site
Lung 13 (21.3) 20 (21.1) 4 (20.0)
Colon 10 (16.4) 7 (7.4) 3 (15.0)
Gynaecological (not breast) 7 (11.5) 5 (5.3) 1 (5.0)
Urinary tract 6 (9.8) 6 (6.3) 2 (10.0)
Breast 4 (6.6) 2 (2.1) 2 (10.0)
Liver 3 (4.9) 8 (8.4) 2 (10.0)
Stomach 4 (6.6) 5 (5.3) 1 (5.0)
Other 9 (14.7) 27 (28.4) 3 (15.0)
Unknown 2 (3.3) 4 (4.2) 0 (0.0)
Not-applicable 3 (4.9) 11 (11.6) 2 (10.0)
Stage
Local/loco-regional disease 16 (26.2) 20 (21.1) 7 (35.0)
Metastasic 42 (68.9) 64 (67.4) 11 (55.0)
Not-applicable 3 (4.9) 11 (11.6) 2 (10.0)
Preceding location
Home 24 (39.3) 25 (26.3) 2 (10.0)
Hospital 37 (60.7) 70 (73.7) 18 (90.0)
Death during hospitalisation 28 (45.9) 87 (91.6) 15 (75.0)
aHigher scores indicate higher cognitive impairment.
bHigher scores indicate better performance status.
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“no”. Twenty-nine patients (47.5%) showed moderate to
severe insomnia according to the SDS. The sleep item of
the SDS that scored the highest was “waking up during
the night”. Patients answering “yes” to the insomnia single
question displayed significantly more frequently moderate
to severe insomnia according to SDS in comparison to
patients answering “occasionally” or “no” (78.9% vs 34.8%;
p = 0.001).
Twenty-one patients (34.4%) reported < 5 hours sleep
per night. Insomnia had often started together with the
current disease (44.3%), and less frequently since admis-
sion to the PCU (11.5%) (results not shown in the table).
Seventy percent of the patients were moderately worried
about insomnia (information not shown in the table).Feeling of non-restorative sleep and daytime sleepiness
were frequent (52.5% and 73.8% of the participants
respectively).
Frequency of emotional distress and other potentially
associated factors
Results on the frequency of emotional distress and other
factors potentially associated with insomnia are displayed
in Table 3. The mean HADS score was 21.6 ± 7.66. Thirty-
nine participants (63.9%) showed clinically significant
emotional distress, 38 (62.3%) depressed mood and 33
(54.1%) anxiety. Nocturnal rumination and feelings of fear
or loneliness were frequent. Pain was the most frequently
claimed physical symptom interfering with sleep quality,
followed by dyspnoea and cough. Most patients reported
Table 2 Frequency of insomnia and other aspects in
relation with insomnia (n = 61)
Frequency of insomnia
Single question
Have you been suffering from insomnia since your
admission?
n (%)
No 10 (16.4)
Occasionally 13 (21.3)
Yes 38 (62.3)
Sleep disturbance scale
During the time you have been hospitalised have
you suffered from…?
n (%)
Difficulty in falling asleepa (mean ± SD) 4.5 ± 2.67
<5 28 (45.9)
≥5 33 (54.1)
Waking up during the nighta (mean ± SD) 4.9 ± 2.31
<5 23 (37.7)
≥5 38 (62.3)
Waking up too early in the morninga (mean ± SD) 4.0 ± 2.65
<5 30 (49.2)
≥5 31 (50.8)
Overall sleep disturbance scale score (range 0-10)b
(mean ± SD)
4.5 ± 1.96
<5 32 (52.5)
≥5 29 (47.5)
Prevalence of additional aspects related to insomnia n (%)
Daytime sleepiness 45 (73.8)
Feeling of non-restorative sleep 32 (52.5)
aLikert 0-10.
bOverall Sleep Disturbance Scale score is calculated as the average of the
rated scores of the three sleep items, a score ≥ 5 indicating moderate to
severe insomnia.
Table 3 Frequency of factors potentially associated with
insomnia (n = 61)
Yes (n(%))
Psychological factors
HADS score (range 0-42)a (mean ± SD) 21.6 ± 7.66
Clinically significant emotional distressb 39 (63.9)
Depressed moodc 38 (62.3)
Anxietyd 33 (54.1)
Nightmares 16 (26.2)
Rumination 48 (78.7)
Feelings of fear/loneliness 30 (49.2)
Clear knowledge diagnosis 39 (63.9)
Clear knowledge prognosis 12 (19.7)
Physical symptoms claimed to be interfering with sleep quality
Pain 42 (68.9)
Dyspnoea 22 (36.1)
Cough 18 (29.5)
Nausea/vomiting 15 (24.6)
Sweating 13 (21.3)
Nycturia 11 (18.0)
Functional incontinence 8 (13.1)
Itch 7 (11.5)
Restless-legs 5 (8.2)
Drug/tobacco abstinence 5 (8.2)
Fever 1 (1.6)
Environmental factors
Reported environmental factor influencing sleep quality 47 (77.0)
Individual room 28 (29.5)
Sleep habits not accomplished 19 (31.1)
Accompanied by a next of kin during night 15 (24.6)
aHospital Anxiety and Depression Scale, higher scores indicate higher
emotional distress.
bHADS score ≥ 19.
cHADD (subscale depression of HADS) ≥ 11.
dHADA (subscale anxiety of HADS) ≥ 11.
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quality of their sleep.
Patients’ perspective on the group of factors that
interfered most
When asked which group of factors interfered most with
sleep quality, most patients (68.9%) mentioned the physical
group; the environmental and psychological factors were
mentioned less (11.5% and 9.8% respectively).
Factors associated with insomnia
Table 4 shows the results of the univariate analysis for
associations between the studied variables and insomnia
or moderate to severe insomnia according to the single
question and the SDS respectively. A higher HADS score
and anxiety, but not clinically significant emotional
distress or depression, were significantly associated with
answering “yes” to the single insomnia question. Neither a
higher HADS score, nor clinically significant emotionaldistress, anxiety or depressed mood were associated with
moderate to severe insomnia measured by the SDS.
In the multivariate regression analysis, insomnia ac-
cording to the single question remained associated with
dyspnoea (OR 7.2 [1.65-31.27] p = 0.009), nocturnal rumin-
ation (OR 5.5 [1.05-28.49] p = 0.04) and higher perform-
ance status (OR 14.3 [1.62-125.43] p = 0.017). Moderate to
severe insomnia according to the SDS was associated with
nocturnal rumination (OR 5.6 [1.1-29.1]; p = 0.041), and
inversely associated with daytime sleepiness (OR 0.25
[0.07-0.9]; p = 0.043).
Discussion
The frequency of insomnia among the patients admitted
to the Palliative Care Unit (PCU) was considerably high
Table 4 Relationship between studied variables and insomnia according to the single question and the SDS (n = 61)
Insomnia (single question) Moderate-severe insomnia (SDS)
No or occasionally (n (%)) Yes (n (%)) p-value No (n (%)) Yes (n (%)) p-value
Socio-demographic/clinical characteristics
Mean age ± SD, years 74.3 ± 9.73 69.8 ± 11.49 0.072 73.2 ± 9.95 69.6 ± 11.96 0.289
Sex 0.33 0.102
Women 12 (44.4) 15 (55.6) 11 (40.7) 16 (59.3)
Men 11 (32.4) 23 (67.6) 21 (61.8) 13 (38.2)
Karnofsky index 0.003a 0.048
> 50 1 (6.3) 15 (93.8) 27 (60.0) 18 (40.0)
≤ 50 22 (48.9) 23 (51.1) 5 (31.3) 11 (68.8)
Procedence 0.11 0.060
Home 12 (50.0) 12 (50.0) 9 (37.5) 15 (62.5)
Acute care 11 (29.7) 26 (70.3) 23 (62.2) 14 (37.8)
Death during hospitalisation 0.768 0.088
No 13 (39.4) 20 (60.6) 18 (64.3) 10 (35.7)
Yes 10 (35.7) 18 (64.3) 14 (42.4) 19 (57.6)
Cancer siteb 0.056 0.534
Lung 2 (15.4) 11 (84.6) 8 (61.5) 5 (38.5)
Other 21 (46.6) 24 (53.3) 22 (48.9) 23 (51.1)
Non-applicable 0 (0.0) 3 (100.0) 2 (66.7) 1 (33.3)
Stageb 0.239 0.888
Local or loco-regional disease 9 (56.3) 8 (43.8) 9 (56.2) 7 (43.5)
Metastasic 14 (33.3) 28 (66.7) 21 (50.0) 21 (50.0)
Non-applicable 0 (0.0) 3 (100.0) 2 (66.7) 1 (33.3)
Psychological factors
HADS (range 0-42) (mean ± SD) 18.2 ± 7.64 23.7 ± 6.98 0.012 20.3 ± 7.79 23.1 ± 7.44 0.158
HADS ≥ 19c 0.137 0.806
No 11 (50.0) 11 (50.0) 12 (54.5) 10 (45.5)
Yes 12 (30.8) 27 (69.2) 20 (51.3) 19 (48.7)
HADD ≥ 11d 0.204 0.306
No 11 (47.8) 12 (52.2) 14 (60.9) 9 (39.1)
Yes 12 (31.6) 26 (68.4) 18 (47.4) 20 (52.6)
HADA ≥ 11e 0.019 0.234
No 15 (53.6) 13 (46.4) 17 (60.7) 11 (39.3)
Yes 8 (24.2) 25 (75.7) 15 (45.4) 18 (54.5)
Nightmares 0.535 0.163
No 18 (40.0) 27 (60.0) 26 (57.8) 19 (42.2)
Yes 5 (31.3) 11 (68.8) 6 (37.5) 10 (62.5)
Rumination 0.012a 0.009a
No 9 (69.2) 4 (30.8) 11 (86.4) 2 (15.4)
Yes 14 (29.2) 34 (70.8) 21 (43.8) 27 (56.3)
Feelings of fear/loneliness 0.222 0.055
No 14 (45.2) 17 (54.8) 20 (64.5) 11 (35.5)
Yes 9 (30.0) 21 (70.0) 12 (40.0) 18 (60.0)
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Table 4 Relationship between studied variables and insomnia according to the single question and the SDS (n = 61)
(Continued)
Clear knowledge of diagnosis 0.042 0.065
No 12 (54.5) 10 (45.5) 17 (43.6) 22 (56.4)
Yes 11 (28.2) 28 (71.8) 15 (68.2) 7 (31.8)
Clear knowledge of prognosis 0.751 0.404
No 18 (36.7) 31 (63.3) 5 (41.7) 7 (58.3)
Yes 5 (41.7) 7 (58.3) 27 (55.1) 22 (44.9)
Physical factorsf
Pain 0.633 0.986
No 8 (42.1) 11 (57.9) 10 (52.6) 9 (47.4)
Yes 15 (35.7) 27 (64.3) 22 (52.4) 20 (47.6)
Dyspnoea 0.018a 0.436
No 19 (48.7) 20 (51.3) 19 (58.7) 20 (51.3)
Yes 4 (18.2) 18 (81.8) 13 (59.1) 9 (40.9)
Cough 0.649 0.381
No 17 (39.5) 26 (60.5) 21 (48.8) 22 (51.2)
Yes 6 (33.3) 12 (66.7) 11 (61.1) 7 (38.9)
Nausea/vomiting 0.150 0.501
No 15 (32.6) 31 (67.4) 23 (50.0) 23 (50.0)
Yes 8 (53.3) 7 (46.7) 9 (60.0) 6 (40.0)
Sweating 0.530 0.910
No 17 (35.4) 31 (64.6) 25 (52.1) 23 (47.9)
Yes 6 (46.2) 7 (53.8) 7 (53.8) 6 (46.2)
Nycturia 1.000 0.412
No 19 (38.0) 31 (62.0) 25 (50.0) 25 (50.0)
Yes 4 (36.0) 7 (63.6) 7 (63.6) 4 (36.4)
Environmental factors
Environmental disturbances 0.650 0.026
No 6 (42.9) 8 (57.1) 11 (78.6) 3 (21.4)
Yes 17 (36.2) 30 (63.8) 21 (44.7) 26 (55.3)
Individual room 0.301 0.754
No 18 (41.9) 25 (58.1) 22 (51.2) 21 (48.8)
Yes 5 (27.8) 13 (72.2) 10 (55.6) 8 (44.4)
Accompanied by next of kin during night 0.310 0.204
No 19 (41.3) 27 (58.7) 22 (47.8) 24 (52.2)
Yes 4 (26.7) 11 (73.3) 10 (66.7) 5 (33.3)
Sleeping habits not accomplished 0.217 0.276
No 18 (42.9) 24 (57.1) 24 (57.1) 18 (42.9)
Yes 5 (26.3) 14 (73.7) 8 (42.1) 11 (57.9)
Additional aspects related to insomnia
Daytime sleepiness 0.237 0.010a
No 8 (50.0) 8 (50.0) 4 (25.0) 12 (75.0)
Yes 15 (33.3) 30 (66.7) 28 (62.2) 17 (37.8)
Feeling of non-restorative sleep 0.007 0.913
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Table 4 Relationship between studied variables and insomnia according to the single question and the SDS (n = 61)
(Continued)
No 16 (55.2) 13 (44.8) 15 (51.7) 14 (48.3)
Yes 7 (21.9) 25 (78.1) 17 (53.1) 15 (46.9)
aStatistical significance persisted after multivariate analysis.
bStatistical analysis excluded the 3rd group (non-applicable).
HADS: Hospital Anxiety and Depression Scale (higher scores indicate higher emotional distress).
cIndicating clinically significant emotional distress.
HADD: subscale Depression of HADS.
dIndicating depressed mood.
HADA: subscale Anxiety of HADS.
eIndicating anxiety.
fOnly those reported by > 8 patients presented.
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and with the Sleep Disturbance Scale (SDS) (47.5% mod-
erate to severe insomnia). Results of the two instruments
correlated significantly with each other. These results
are comparable to those on insomnia prevalence existing
in the literature. Studies using the Pittsburg Sleep Quality
Index (PSQI) found prevalences of 73% to 96% of “poor
sleepers” using different cut-off scores [5,11]. Other studies
showed prevalences of 72% and 45% using a constructed
questionnaire and one item of the major depressive episode
module of the Structured Clinical Interview for DSM-IIIR
(SCID), respectively [4,25]. A prevalence of 70% was found
in another study by asking the single question “Do you have
trouble sleeping at night?” [12].
The single question “Have you been suffering from
insomnia since your admission?” might be a sensitive
method for detecting insomnia. However, the use of a
single question has been considered as insufficient for
the evaluation of insomnia in cancer patients, as it may
have poor sensitivity and specificity for detecting in-
somnia [32]. In the present study, patients with higher
HADS score, more anxiety, clear knowledge of the
diagnosis, better performance status, nocturnal rumin-
ation, “dyspnoea” as a symptom interfering with sleep
quality, and a feeling of non-restorative sleep answered
more often “yes” to this single question in the univariate
analysis.
The SDS assesses the presence of moderate to severe
insomnia, is easy and quick to administrate, refers to a
short recent period, and gives information about the
three sleep items: falling asleep, waking up during the
night and early waking. The use of a Likert scoring system
allows participants to respond in a degree of agreement
accommodating neutral or undecided feelings, and with-
out requiring them to provide a simple and concrete yes
or no answer [33]. Therefore, the assessment of insomnia
of patients during admission in a PCU using SDS may
have some advantages over the insomnia single question
and other tools which take longer to respond to and refer
to a longer preceding period of time. In the present study,
patients with better performance status, nocturnal rumin-
ation, patients referring environmental disturbances anddaytime sleepiness showed more moderate to severe in-
somnia in the univariate analysis.
The most affected sleep item was sleep maintenance,
followed by difficulties in falling asleep and early waking,
coinciding with data from other studies on patients with
cancer [9,14].
Clinically significant emotional distress was frequent
in this study. A higher HADS score and the presence of
anxiety were associated with answering “yes” to the in-
somnia single question in the univariate analysis, but this
association was not found in the multivariate analysis, and
no association was found with clinically significant emo-
tional distress. Moderate to severe insomnia measured
with the SDS was not associated with clinically significant
emotional distress, higher HADS score, anxiety or depres-
sion. These results contrast with those in previous studies
reporting on a correlation between insomnia and anxiety
and/or depression measured with an analogue visual scale
as part of the Edmonton Symptom Assessment System
[34] in palliative patients [13,16], or with a recent study
reporting on a correlation between insomnia severity and
depression measured using a non-validated tool [35].
Another recent study found a significant correlation
between emotional distress measured with the HADS
and insomnia measured with Athens Sleep Insomnia
Scale [36] among patients with lung cancer [37].
Nevertheless, in the present study the psychological
symptom nocturnal rumination did show a significant
association with insomnia assessed with both instruments.
In the unwanted mental activity at bedtime, rumination is
a dysfunctional control strategy used by poor sleepers,
which maintains cognitive and affective arousal instead
of helping them to relax [3,38]. The association between
rumination and insomnia is consistent throughout the
literature [3,12,14,31,38,39]. Rumination has been asso-
ciated with an increased and prolonged emotional dis-
tress (i.e. depression and anxiety) and with physical
health problems in palliative care patients [40] and in
the general population [38,41,42]. However, some recent
studies have suggested that rumination may contribute
to clinical insomnia, irrespective of worry and depressed
mood states [39,43,44].
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posed in the literature [31,41,43,45], but only few have
been used in palliative care patients [30,40]. In the present
study, rumination was evaluated by means of a simple
question based on a definition obtained from the literature
[30,31]. Several methods for managing rumination have
been also developed, and it has been proposed that its
treatment may be imperative for a successful management
of insomnia and depression [31,45]. Strategies aimed at
improving rumination could be included into the cogni-
tive behavioral therapy of insomnia [31,45].
Despite the association and possible role of rumination
in connection with insomnia, patients in this study
claimed physical factors to be the type of symptoms that
interfered most with their sleep quality, coinciding with
results reported in other studies [12]. This result suggests
that patients may tend to underreport psychological
symptoms such as rumination, but also highlights the im-
portance of careful evaluation of physical symptoms.
Among the physical factors, pain was the symptom that
patients mentioned most often as interfering with their
sleep quality, suggesting that pain should be especially
taken into consideration when assessing and managing in-
somnia, as reported in other studies [11,14]. Nevertheless,
pain was not found associated with insomnia in the multi-
variate regression analysis in the present study.
Dyspnoea showed a significant association with insom-
nia measured with the single question in the multivariate
regression analysis. Dyspnoea has been also reported in
the literature as being the cause of sleep disturbance
[12,46]. However, this association has not been confirmed
in other studies [4]. Also a higher performance status
(higher Karnofsky index) has shown association with
insomnia measured with the single question in the
multivariate regression analysis of this study. Unlike
this study, other studies found that a lower performance
status might be associated with insomnia [4,11]; however,
these results were not confirmed in the multivariate
analyses of these studies. Results regarding the Karnofsky
index in the present study should be interpreted cau-
tiously, as the range of performance status included was
limited by the inclusion criteria.
Patients with daytime sleepiness in this study showed
moderate to severe insomnia less often according to the
SDS, in comparison to those patients without daytime
sleepiness (37.8% vs 75.0%), suggesting that patients with
moderate to severe insomnia might be more often awake
in PCUs during the daytime. In a secondary analysis,
daytime sleepiness was associated with a higher intake of
psychotropic medication; it could be hypothesized that
sleepiness due to psychotropic medication might also be
happening at night. Literature on the relationship be-
tween daytime sleepiness and insomnia in palliative
care is scarce. Although there is some controversy, ourresult is comparable with other studies [46,47]. Never-
theless, excessive daytime sleepiness in the general
adult population seems more likely to be attributed to
short sleep duration [48], but the insufficient sleep can
be due to insomnia or to other factors. Pharmaco-
logical treatment and biological aspects associated with
advanced cancer, such as cytokines influencing the
sleep-wake cycle [49], could influence the presence of
daytime sleepiness. Further studies are needed in order to
understand the relationship between daytime sleepiness
and insomnia.
To the best of our knowledge, environmental factors
have rarely been considered in the literature in relation
to insomnia. Despite not being significantly associated
with insomnia in the multivariate analysis, results of this
study show that patients do care about environmental
factors with regard to their sleep. Although PCUs are
generally quieter than other conventional hospital wards,
this result suggests that special care should be taken to
ensure that these units are free of unnecessary noise, light
or other interruptions during the night-time. As suggested
by the hyperarousal theory, patients with insomnia might
find themselves in a cycle of increased cognitive and
physiological sustained sensory processing of environmen-
tal stimuli [50,51].
In the present study no association between insomnia
and other sociodemographic (e.g. gender, age) or clinical
characteristics (e.g. diagnosis and stage of the disease,
medication use) was found.
This study has limitations. The low sample size does
not allow us to speak about prevalence of insomnia and
limits the interpretation of the results of the multivariate
analysis. This study should be seen as exploratory. Repli-
cation of the results in further studies with larger sample
sizes is required. The SDS was translated into the Catalan
language, but no backward translation was performed, as
recommended by methodological literature [52]. However,
the items were not complex in terms of language and no
important cultural differences were expected after transla-
tion. Furthermore, no formal validation of the scale was
carried out.
The day during admission on which interviews took
place varied, with some taking place after one week of
admission. Only 36% of the consecutively admitted
patients were included in the study. About 10% of the
admitted patients were not assessed for inclusion because
they were discharged or died before, but their sociodemo-
graphic characteristics did not differ from the other pa-
tients admitted. More than half of the admitted patients
were excluded because they were too confused or had a
too bad performance status, similar to that experienced in
other studies [4]. Results of the present study may not be
representative of all patients admitted, but of those with
better cognitive and performance status.
Renom-Guiteras et al. BMC Palliative Care 2014, 13:40 Page 11 of 12
http://www.biomedcentral.com/1472-684X/13/40Conclusions
In conclusion, this study suggests a high frequency of
insomnia among palliative care patients during their
admission in a PCU, both when measured using a short
single question and the Sleep Disturbance Scale. Further-
more, a high frequency of clinically significant emotional
distress (including anxiety and depression) was shown.
Pain, dyspnoea and environmental factors were often
mentioned by patients as interfering with their sleep
quality, and patients mentioned physical factors as the
type of factor interfering most. While clinically significant
emotional distress was not associated with insomnia in
this study, nocturnal rumination was associated with
insomnia when measured with both tools and this
association remained in the multivariate analysis. The
assessment of nocturnal rumination might be of particular
interest in the management of insomnia. These results
should be confirmed in further prospective studies with a
larger sample size.
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